US FDA’s Amy Abernethy Leaves Behind Legacy Of Tech Modernization, Real-World Data

 
• By Sue Sutter
Amy Abernethy 2020
Amy Abernethy will depart the FDA in April after more than two years as principal deputy commissioner. • Source: FDA

More from Real-World Evidence

More from Clinical Trials